Unternehmen Cocrystal Pharma Inc OTC Bulletin Board
Aktien
US19188J1025
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Sam Lee
CEO | Chief Executive Officer | 64 | 02.01.14 |
James Martin
CEO | Chief Executive Officer | 57 | 23.02.17 |
Roger Kornberg
CHM | Chairman | 76 | 02.01.14 |
Luz Pascual
CTO | Chief Tech/Sci/R&D Officer | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Phillip Frost
BRD | Director/Board Member | 87 | 02.01.14 |
Director/Board Member | 68 | 27.05.21 | |
Steven Rubin
BRD | Director/Board Member | 63 | 02.01.14 |
Fred Hassan
BRD | Director/Board Member | 78 | 20.04.23 |
Anthony Japour
BRD | Director/Board Member | 64 | 04.04.19 |
Roger Kornberg
CHM | Chairman | 76 | 02.01.14 |
Sam Lee
CEO | Chief Executive Officer | 64 | 02.01.14 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 10 173 790 | 7 118 419 ( 69,97 %) | 0 | 69,97 % |
Unternehmenskontakt
Cocrystal Pharma, Inc.
19805 North Creek Parkway
98011, Bothell
+877 262 7123
http://www.cocrystalpharma.com![Straße Cocrystal Pharma Inc](https://cdn.zonebourse.com/static/address/16279122.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+16,13 % | 122 Mrd. | |
+19,65 % | 115 Mrd. | |
+21,22 % | 26,64 Mrd. | |
-23,84 % | 19,91 Mrd. | |
-17,47 % | 16,32 Mrd. | |
-45,95 % | 15,52 Mrd. | |
-19,28 % | 15,49 Mrd. | |
+63,81 % | 14,83 Mrd. | |
+1,94 % | 13,67 Mrd. |